Examining the European Pharma legislation: EFPIA publishes the Dolon Report
Examining the European Pharma legislation: EFPIA publishes the Dolon Report
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has commissioned Dolon to develop a report to assess the impact of the proposed European Commission pharma legislation. The Dolon Report, published on 6 November, has projected that the proposed legislation will negatively impact research and development in the pharmaceutical industry in Europe, potentially impacting the lives of patients around the world. Below are some of the projected outcomes if the legislation is adopted.
![](https://www.ipsen.com/websites/ipsen_com_v2/wp-content/uploads/2023/11/10102815/Image1-1.png)
![](https://www.ipsen.com/websites/ipsen_com_v2/wp-content/uploads/2023/11/10102815/Image2-1.png)
![](https://www.ipsen.com/websites/ipsen_com_v2/wp-content/uploads/2023/11/10102815/Image3-1.png)
Find out more about the potential impact: read EFPIA’s press release here and the full report here.
Examining the European Pharma legislation: EFPIA publishes the Dolon Report
![Examining the European Pharma legislation: EFPIA publishes the Dolon Report Examining the European Pharma legislation: EFPIA publishes the Dolon Report](https://www.ipsen.com/websites/ipsen_com_v2/wp-content/uploads/2023/11/10103141/Thumbnail_EFPIA_Dolon-Report_1082x620pix.jpg)
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has commissioned Dolon to develop a report to assess the impact of the proposed European Commission pharma legislation. The Dolon Report, published on 6 November, has projected that the proposed legislation will negatively impact research and development in the pharmaceutical industry in Europe, potentially impacting the lives of patients around the world. Below are some of the projected outcomes if the legislation is adopted.
![](https://www.ipsen.com/websites/ipsen_com_v2/wp-content/uploads/2023/11/10102815/Image1-1.png)
![](https://www.ipsen.com/websites/ipsen_com_v2/wp-content/uploads/2023/11/10102815/Image2-1.png)
![](https://www.ipsen.com/websites/ipsen_com_v2/wp-content/uploads/2023/11/10102815/Image3-1.png)
Find out more about the potential impact: read EFPIA’s press release here and the full report here.
Related Stories
![Financial results for the first half of 2024 Financial results for the first half of 2024](https://www.ipsen.com/websites/ipsen_com_v2/wp-content/uploads/2024/07/22170035/Boulogne-France-img-15-S-1-1.png)
Financial results for the first half of 2024
![Our 2023 Integrated Annual Report is live! Our 2023 Integrated Annual Report is live!](https://www.ipsen.com/websites/ipsen_com_v2/wp-content/uploads/2024/05/17174619/TL-graphic.jpg)
Our 2023 Integrated Annual Report is live!
![Q1 2024 sales update Q1 2024 sales update](https://www.ipsen.com/websites/ipsen_com_v2/wp-content/uploads/2024/04/19163230/Boulogne-France-img-15-S-1-1.png)
Q1 2024 sales update
![Applications now open for the 2024 Golden Ticket competition Applications now open for the 2024 Golden Ticket competition](https://www.ipsen.com/websites/ipsen_com_v2/wp-content/uploads/2023/05/11162843/Module-9-%E2%80%93-Lay-language-summaries_IPSEN_Production_Signes_056-1.jpg)
Applications now open for the 2024 Golden Ticket competition
![FY 2023 results announcement FY 2023 results announcement](https://www.ipsen.com/websites/ipsen_com_v2/wp-content/uploads/2024/02/02061917/Thumbnail_CMD-2023_1082x620pix_2.jpeg)
FY 2023 results announcement
![Ipsen sponsors 5 elite athletes on their journeys to the 2024 Paralympics Ipsen sponsors 5 elite athletes on their journeys to the 2024 Paralympics](https://www.ipsen.com/websites/ipsen_com_v2/wp-content/uploads/2023/11/20145625/20231120_Paralympics_Ipsen-com_1082x620pix-1.jpg)
Ipsen sponsors 5 elite athletes on their journeys to the 2024 Paralympics
![Capital Markets Day 2023 Capital Markets Day 2023](https://www.ipsen.com/websites/ipsen_com_v2/wp-content/uploads/2023/10/31171527/Thumbnail_CMD-2023_1082x620pix.jpeg)
Capital Markets Day 2023
![2023 year to date and third-quarter sales results 2023 year to date and third-quarter sales results](https://www.ipsen.com/websites/ipsen_com_v2/wp-content/uploads/2022/10/05100901/202105_Images_346x346pix_1-1.jpeg)
2023 year to date and third-quarter sales results
![Winner of Ipsen’s golden ticket announced as newest resident of Biolabs Hôtel Dieu Winner of Ipsen’s golden ticket announced as newest resident of Biolabs Hôtel Dieu](https://www.ipsen.com/websites/ipsen_com_v2/wp-content/uploads/2023/07/20092413/13359_AKT-IPS_Winner-Social-Card_1200x672_RGB_02-1.jpg)
Winner of Ipsen’s golden ticket announced as newest resident of Biolabs Hôtel Dieu
![David Loew, Philippe Lopes Fernandes inaugurate Biolabs – Hôtel Dieu David Loew, Philippe Lopes Fernandes inaugurate Biolabs – Hôtel Dieu](https://www.ipsen.com/websites/ipsen_com_v2/wp-content/uploads/2023/07/07164032/MicrosoftTeams-image-1.png)